US Stock MarketDetailed Quotes

FULC Fulcrum Therapeutics

Watchlist
  • 4.350
  • +0.320+7.94%
Close Dec 20 16:00 ET
  • 4.350
  • 0.0000.00%
Post 18:05 ET
234.63MMarket Cap-15.00P/E (TTM)

Fulcrum Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Fulcrum Therapeutics Q3 2024 Earnings Date

Currency：USDNov 13, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
0
0
0
-100.00%
-100.00%
--
EPS
-0.40
-0.35
+0.05
Beat Est.
-2.56%
+10.26%
+12.48%
Analyst Rating
Buy

Dec 21, 2024

Fulcrum Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
Nov 13, 20242024/Q30.000 / 0.000--
Jul 31, 20242024/Q280.000M / 41.113M--
May 13, 20242024/Q10.000 / 360.140K--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
Nov 13, 20242024/Q30.000 / 0.000--
Jul 31, 20242024/Q280.000M / 41.113M--
May 13, 20242024/Q10.000 / 360.140K--

Unlock Free Earnings Estimates

Fulcrum Therapeutics Earnings Reports

  • Fulcrum Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 13 07:13 ET

  • Fulcrum Therapeutics | 10-Q: Q2 2024 Earnings Report

    Jul 31 07:21 ET

  • Fulcrum Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 13 07:19 ET

  • Fulcrum Therapeutics | 10-K: FY2023 Annual Report

    Feb 27 16:10 ET

    • Read more

    Trending US Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Ermenegildo Zegna NV
    ZGN
    +6.16%
    DexCom
    DXCM
    +5.57%
    New Fortress Energy
    NFE
    +5.37%
    Workday
    WDAY
    +2.33%
    eBay
    EBAY
    +1.66%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Dec 21, 2024

    Buy

    • Buy

      25.00%

    • Hold

      75.00%

    • Sell

      0.00%

    Price Target

    No Data